{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T12:50:13Z","timestamp":1786625413008,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","issue":"28","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.vaccine.2019.07.101","type":"journal-article","created":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T17:32:11Z","timestamp":1566322331000},"page":"4485-4486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The future of vaccine development"],"prefix":"10.1016","volume":"38","author":[{"given":"Wayne C.","family":"Koff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore","family":"Schenkelberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.07.101_b0005","unstructured":"Centers for Disease C, Prevention. Control of infectious diseases. MMWR Morb Mortal Wkly Rep; 1999; 48: 621\u20139."},{"issue":"6136","key":"10.1016\/j.vaccine.2019.07.101_b0010","doi-asserted-by":"crossref","first-page":"1232910","DOI":"10.1126\/science.1232910","article-title":"Accelerating next generation vaccine development for global disease prevention","volume":"340","author":"Koff","year":"2013","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.vaccine.2019.07.101_b0015","doi-asserted-by":"crossref","first-page":"e57755","DOI":"10.1371\/journal.pone.0057755","article-title":"Risk in vaccine research and development quantified","volume":"8","author":"Pronker","year":"2013","journal-title":"PLoS"},{"issue":"7","key":"10.1016\/j.vaccine.2019.07.101_b0020","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/ni.2871","article-title":"Toward a human vaccines project","volume":"15","author":"Koff","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2019.07.101_b0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-019-0934-8","article-title":"High frequency of shared clonotypes in human B cell receptor repertoires","author":"Soto","year":"2019","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.vaccine.2019.07.101_b0030","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.it.2016.05.005","article-title":"Towards predicting protective vaccine responses in the very young","volume":"37","author":"Kollmann","year":"2016","journal-title":"Trends Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2019.07.101_b0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13073-018-0584-8","article-title":"Advanced model systems and tools for basic and translational human immunology","volume":"10","author":"Wagar","year":"2018","journal-title":"Genome Med"},{"issue":"28","key":"10.1016\/j.vaccine.2019.07.101_b0040","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aar3947","article-title":"A subset of HLA-I peptides are not genomically templated: Evidence for cis- and trans-spliced peptide ligands","volume":"3","author":"Faridi","year":"2018","journal-title":"Sci Immunol."},{"key":"10.1016\/j.vaccine.2019.07.101_b0045","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.coi.2018.08.002","article-title":"When designing vaccines, consider the starting material: the human B cell repertoire","volume":"53","author":"Havenar-Daughton","year":"2018","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2019.07.101_b0050","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1172\/JCI126046","article-title":"Immunotherapy transforms cancer treatment","volume":"129","author":"Zaidi","year":"2019","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.vaccine.2019.07.101_b0055","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","article-title":"Immunity and Inflammation in atherosclerosis","volume":"124","author":"Wolf","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.vaccine.2019.07.101_b0060","article-title":"Active vaccination for neurological disorders","author":"Verma","year":"2019","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2019.07.101_b0065","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41591-018-0008-8","article-title":"Transcript-indexed ATAC-seq for precision immune profiling","volume":"24","author":"Satpathy","year":"2018","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.vaccine.2019.07.101_b0070","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00281-017-0653-x","article-title":"Transfer of maternal immunity and programming of the newborn immune system","volume":"39","author":"Jennewein","year":"2017","journal-title":"Semin Immunopathol"},{"issue":"1","key":"10.1016\/j.vaccine.2019.07.101_b0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/21645515.2016.1225635","article-title":"From discovery to licensure, the Adjuvant System story","volume":"13","author":"Gar\u00e7on","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.07.101_b0080","doi-asserted-by":"crossref","unstructured":"Kreimer AR, Herrero R, Sampson JN, Porras C, Lowy DR, Schiller JT, et al., Costa Rica HPV Vaccine Trial (CVT) Group. Evidence for single-dose protection by the bivalent HPV vaccine-review of the costa rica HPV vaccine trial and future research studies. Vaccine 2018;36(32 Pt A):4774\u201382 [Epub 2018 Feb 1]. doi:10.1016\/j.vaccine.2017.12.078.","DOI":"10.1016\/j.vaccine.2017.12.078"},{"issue":"2","key":"10.1016\/j.vaccine.2019.07.101_b0085","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41590-017-0027-5","article-title":"Local proliferation maintains a stable pool of tissue-resident memory T cells after antiviral recall responses","volume":"19","author":"Park","year":"2018","journal-title":"Nat Immunol"},{"issue":"R1","key":"10.1016\/j.vaccine.2019.07.101_b0090","doi-asserted-by":"crossref","first-page":"R40","DOI":"10.1093\/hmg\/ddy100","article-title":"Cell type discovery using single-cell transcriptomics: implications for ontological representation","volume":"27","author":"Aevermann","year":"2018","journal-title":"Hum Mol Genet."},{"key":"10.1016\/j.vaccine.2019.07.101_b0095","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiy745","article-title":"New vaccine design and delivery technologies","author":"Kanekiyo","year":"2019","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2019.07.101_b0100","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41596-018-0111-9","article-title":"Using enhanced number and brightness to measure protein oligomerization dynamics in live cells","volume":"14","author":"Cutrale","year":"2019","journal-title":"Nat Protoc"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19310229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19310229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:45:09Z","timestamp":1759401909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19310229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":20,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0264410X19310229"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.101","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The future of vaccine development","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}